COMPANY PROFILE

Clarapath

Clarapath will transform anatomic pathology through its holistic approach to high-throughput slide production, imaging and analysis

Town of Mount Pleasant, United StatesFounded 2014Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2024

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Clarapath

Clarapath operates in the healthcare sector, specifically within the pathology and laboratory services market. The company has developed the SectionStar, an automated and robotic device that streamlines nine labor-intensive microtomy steps into a single piece of equipment. This innovation results in higher quality slides, faster turnaround times, and reduced costs. Clarapath also runs a CLIA certified lab offering a variety of Contract Research Organization (CRO) services, including Routine Histology, Whole Slide Imaging, Quantitative Image Analysis, and Data Hosting Management. The primary clients served by Clarapath include hospitals, research institutions, and pharmaceutical companies. The business model revolves around selling the SectionStar device and providing lab services on a contract basis. Revenue is generated through the sale of the SectionStar device and fees for lab services. Keywords: Automated pathology, robotic microtomy, CLIA certified lab, Routine Histology, Whole Slide Imaging, Quantitative Image Analysis, Data Hosting, healthcare innovation, laboratory efficiency, cost reduction.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2014
Headquarters: Town of Mount Pleasant, United States
Employees: 64
Open positions: 9
Dealroom signal: 37.4/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Core AI, Spinout, AI Applications, DT and LS, science-based
Technology: Artificial Intelligence
Business model: Manufacturing
Client focus: b2b
Investment activity: 1 company, latest Feb 2023
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Clarapath.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Jul 2024	$36M	$144M	Ochsner Health · Northwest Venture · Mayo Clinic · CU Healthcare Innovation Fund	↗
SERIES BOther financing	Nov 2021	$32M	$128M	P5 Health Ventures · Northwell Health · East Post Road Ventures	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Clarapath website traffic

Latest recorded traffic for Clarapath is 1.7K monthly website visits, down 48.5% over the last three months. Clarapath's team grew 3.2% over the past year.

Latest monthly visits1.7K 3-month web change-48.5% 1-year team growth+3.2%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Field Application SpecialistNew York, New York, United States, Northern America, Americas · Other · Sep 7, 2026 HistotechnicianNew York, New York, United States, Northern America, Americas · Other · Sep 7, 2026 Senior Field Application SpecialistNew York, New York, United States, Northern America, Americas · CSM & Support · Sep 7, 2026 Field Application SpecialistHawthorne, NY · Other · Sep 2, 2026 Senior Field Application SpecialistHawthorne, NY · CSM & Support · Sep 2, 2026 HistotechnicianHawthorne, NY · Other · Sep 2, 2026 Quality Control TechnicianNew York, New York, United States, Northern America, Americas · Other · Aug 31, 2026 Manager, Information Technology (IT)New York, New York, United States, Northern America, Americas · Data Science & Engineering · Aug 31, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBiotiaHealth tech company providing hospitals with tailored sequencing-based solutions to reduce hospital-acquired infections	New York City, United States	Operational	26	$10M	$32M
DDDay Zero DiagnosticsDeveloping a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy	Boston, United States	Operational
UBuBiomeMicrobiome sequencing service that provides information and tools for users to explore their microbiome	San Francisco, United States	Closed
HLHuman LongevityA genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived	San Diego, United States	Operational
SGSophia GeneticsHelps clinicians and physicians predict genetic diseases better	Saint-Sulpice, Switzerland	Operational
DLDeep LensSaas-based precision medicine software suite	Columbus, United States	Acquired
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
RPRecursion PharmaA clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery	Salt Lake City, United States	Operational